A Texas bankruptcy judge's decision this week to award roughly $400 million to lenders excluded from Serta Simmons' controversial "uptier" deal is poised to transform creditor-on-creditor disputes and shift how debtors decide where to seek Chapter 11 protection.
Eye disease treatment developer Clearside Biomedical received confirmation of its Chapter 11 plan. Dish Wireless sought approval for $85 million in financing. And T-Mobile took issue with SiFi Networks' bid procedures motion.
Microbiome treatment developer Finch Therapeutics will ask a Delaware bankruptcy judge to approve a Chapter 11 plan that would allow it to sell all assets to a rival company and exit bankruptcy. Here's a look at the liquidating plan it is hoping to get confirmed.